VIVITRA 375MG INJECTION

Content Reviewed By:

Written By:

• The protein known as HER2 (human epidermal growth factor receptor 2) is sometimes found in very large amounts on the surface of certain types of cancer cells. When HER2 is overproduced like this, it acts like a signal that constantly tells the cancer cells to grow and divide rapidly. This uncontrolled growth is a major part of how cancer spreads. VIVITRA 375MG INJECTION is a targeted therapy designed to fight these specific cancers. It works by acting like a key that fits only the lock on the HER2 protein. By binding directly to the HER2 receptor on the cancer cell surface, VIVITRA 375MG INJECTION blocks the signals that promote growth. This action effectively stops the cancer cells from receiving the 'grow' message, slowing down or even stopping their uncontrolled multiplication. It's a specific way to target the cancer cells that rely heavily on HER2, aiming to limit harm to healthy cells.

• VIVITRA 375MG INJECTION is a medicine that is given through a drip into your vein. A healthcare professional, usually a doctor or nurse in a clinic or hospital setting, will administer it. This infusion can be given either before or after you have surgery, depending on your specific treatment plan. The first time you receive VIVITRA 375MG INJECTION, the infusion will typically take about 90 minutes to complete. This slower rate allows the healthcare team to monitor you closely for any reactions. If your body tolerates this first dose well, future doses may be given over a shorter period, usually about 30 minutes. It is important that this medication is always given under the supervision of a trained medical professional. Do not attempt to administer this medication yourself. They will ensure you receive the correct dose at the right time and in the proper way. Always follow your doctor's instructions regarding the timing and duration of the treatment.